To evaluate the mechanism of insulin action to increase rat 2sI-labeled insulin-like growth factor II (125I- 
IGF-ll receptors was indicated by the demonstration that control adipocytes could readily adsorb the anti-receptor 1g. These data demonstrate that increased numbers of IGF-II receptors are displayed in an exposed position on the adipocyte cell surface in response to insulin. 16 ). In contrast to the data obtained in intact rat adipocytes, however, we found that the apparent number of IGF-II receptors, as measured by Scatchard analysis of binding data, is increased in the plasma membrane fraction derived from insulin-treated adipocytes (15) . Concomitantly, a decreased apparent number of IGF-II receptors was observed in the low-density microsome fraction of adipocytes incubated with insulin. No differences were found in the affinity for 125I-IGF-II among the receptors in these membrane fractions (15) . These results are of particular interest, considering their analogy to the apparent redistribution of glucose transporters from the low-density microsome to the plasma membrane fraction caused by insulin in rat adipocytes (18, 19) .
Taken together, the data obtained on 1251I-IGF-II binding in intact cells versus isolated membrane fractions raised an important discrepancy in interpretation.
The aim of the present studies was to provide direct data independent of ligand binding that could distinguish between an insulin effect on the affinity versus the number of IGF-II receptors in adipocytes. The strategy used involves the preparation and use of specific anti-IGF-11 receptor Ig for assessing the number of IGF-II receptors on the adipocyte cell surface. We demonstrate here that insulin increases the binding of such anti-receptor antibodies to adipocytes in parallel with its activation of 1251-IGF-II binding, indicating an increased number of receptors on the membrane surface of insulin-treated cells.
Insulin-like growth factor II (IGF-II) is one of a family of growth factors closely related to insulin in its amino acid sequence, structure (1, 2) , and biological activities (3) . A receptor for IGF-II, distinct from the insulin and IGF-I receptors, has been demonstrated in a variety of tissues (4) and has been identified on electrophoretic gels by affinity crosslinking methods (5) (6) (7) . The (8) (9) (10) . The IGF-II receptor structure, also referred to as the type II IGF receptor, binds IGF-II with highest affinity and IGF-I with lower affinity and has no affinity for insulin (6) . The receptor has been purified to homogeneity by affinity purification techniques (11, 12 Preparation of Fat Cells and Plasma Membrane Fraction. Fat cells were isolated from the epididymal fat pads of 140-to 170-g male rats (SD strain, Taconic Farms, Germantown, NY) by the method described by Rodbell (23) . The fat pads were digested for 1 hr at 370C in Krebs-Ringer phosphate buffer (pH 7.4) containing 3% bovine serum albumin (fraction V; Reheis, Kankakee, IL) and collagenase (1 mg/ml; type 1, Worthington). The Krebs-Ringer phosphate buffer contained 128 mM NaCl, 1.4 mM CaC12, 1.4 mM MgSO4, 5.2 mM KCl, and 10 mM Na2HPO4. Isolated fat cells were then filtered through nylon chiffon and washed twice with the above buffer. In some experiments, cells were incubated for 15 min at 37°C in the presence or absence of 10 nM insulin (porcine, Eli Lilly). The number of fat cells was estimated as described by Gliemann (24) .
Plasma membrane fractions were prepared by the differential centrifugation method described by McKeel and Jarett (25) with some modifications. Adipocytes were rinsed with 10 mM Tris HCI/1 mM EDTA/250 mM sucrose, pH 7.4, and homogenized with a Teflon pestle. Each homogenate was centrifuged at 12,000 x g for 15 min. The "g" refers to the average centrifugal force at the midportion of the centrifuge tube. The pellets were homogenized and centrifuged again at 3,000 x g for 10 min. The pellets containing primarily mitochondria and nuclei were discarded, and the supernatant was centrifuged at 28,000 x g for 30 min to sediment the plasma membrane fraction. Protein concentration was determined by the method of Lowry et al. (26) .
'25I-IGF-II and '25I-Labeled Insulin (1251-Insulin) Binding
Assay. Purification of multiplication-stimulating activity, referred to as rat IGF-II (27) in this paper, and its iodination was achieved by using conditioned medium of BRL-3A rat liver cells by the procedure of Marquardt et al. (27) as reported (11) . Purified rat IGF-II, insulin, and goat anti-rabbit IgG (Cappel Laboratories) were iodinated by using an immobilized lactoperoxidase/glucose oxidase mixture (Enzymobeads, Bio-Rad) as described (28) to a specific activity of 100-150 Ci/g, 100-150 Ci/g, and 5-10 Ci/g, respectively (1 Ci = 37 GBq).
Isolated cells (2-3 x 105 cells) were incubated with 1 nM 125I-IGF-11 for 30 min at 21'C in a total volume of 400 ,ul, and binding was determined by the oil flotation method with silicone fluid (29) . Nonspecific binding, measured at 250 nM unlabeled IGF-II, represented =20% of the maximum binding and was subtracted from the data.
Binding of 125I-IGF-II or 125I-insulin to isolated plasma membranes from rat adipocytes was performed by incubation of 115 Ag of plasma membranes with several concentrations of control or anti-receptor Ig for 45 min at room temperature in a total volume of 100 pl, and this mixture was then incubated with 1 nM 125I-IGF-II or 1 nM 125I-insulin for 30 min at room temperature in a total volume of 200 Al of Krebs-Ringer phosphate buffer (pH 7.4) containing 1% bovine serum albumin. Binding was terminated by the addition of 1 ml of ice-cold Krebs-Ringer phosphate buffer (pH 7.4), followed by centrifugation at 13,000 x g for 3 min in a Fisher microcentrifuge. Supernatant was removed by aspiration, 'and the pellet was assayed for radioactivity. Nonspecific binding, determined at 250 nM unlabeled ligand, was subtracted and represented 10-20% of maximum binding.
Binding anti-receptor Ig against purified IGF-II receptor was shown also in the ELISA. Anti-receptor antiserum was very potent and could elicit a positive reaction of binding to IGF-II receptor at a 1:5000 dilution (Fig. 2) . The Ig fraction from the anti-receptor antiserum, prepared by precipitation with ammonium sulfate, was effective in inhibiting 1251-IGF-II binding to its receptor when added prior to IGF-II (Fig. 3) ing to rat adipocyte plasma membrane, suggesting that this antibody is specific for IGF-II receptor (Fig. 3) (17) . Therefore, a failure of the Scatchard analysis in showing a correct apparent number of receptors in intact adipocytes using 125I-IGF-II may be attributed to deviations from experimental conditions where ideal equilibrium binding is achieved. The degradation of 125I-IGF-II was reported to be minimal under these experimental conditions (14) . One possible problem with 1251-IGF-II binding to intact cells is that a significant amount of 125I-IGF-II is internalized during the incubation period. This is suggested by the fact that 1 nM 125I-IGF-II binding was decreased significantly (30-60%) by 2 mM KCN or 1 mM 2,4-dinitrophenol treatment both in control and insulin-treated cells compared to the binding without KCN or 2,4-dinitrophenol treatment, whereas these agents did not inhibit IGF-II binding in isolated membranes (ref. 30; unpublished data). Although much attention has been directed toward mechanisms by which receptors initiate cellular signaling, it is also apparent that receptors play key roles as targets for cellular regulatory mechanisms. Insulin action on the IGF-II receptor represents one such example. The data presented in this paper demonstrating that insulin activates the expression of increased numbers of IGF-I1 receptors on the adipocyte cell surface suggest that this mechanism may be common to other receptor modulations. For example, increased human chorionic gonadotropin receptor activity occurs in response to follicle-stimulating hormone action (31) . Whether this and other examples of increased receptor activity in response to a second receptor signaling mechanism reflects increased numbers of receptors will have to await direct data.
It is interesting that certain other examples of receptor regulation appear to reflect changes in the activities of the receptor structure itself rather than a change in receptor number. Thus, desensitization of the f3-catecholamine recepBiochemistry: Oka et aL tor in turkey erythrocytes is associated with receptor phosphorylation, which may relate to the decreased receptor activity (32) . The ability of 8-catecholamines to inhibit insulin receptor binding to 125I-insulin in adipocytes also appears not to be associated with a decrease in the total number of receptors present on the cell surface (ref. 33 ; unpublished data). Thus, it seems reasonable to conclude that mechanisms other than changes in receptor number also operate to regulate receptor function in some systems.
The data presented here raise important questions about the location of the pool of nonexposed IGF-I1 receptors that are acted upon by insulin as well as the mechanisms by which this mobilization occurs. A possible cellular locus for the IGF-II receptors may be intracellular vesicles that mediate IGF-II receptor recycling between the cell-surface membrane and cell cytoplasm. However, we cannot eliminate the possibility that specialized domains of the plasma membrane may exist in exposed as well as nonexposed dispositions.
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